Search

everythinglearnresearchcommunity

for

Search:↓

Skin and mucous membrane issues are common in kids after bone marrow transplants, so careful monitoring is crucial.

Better hair care products are needed to protect against grooming and chemical damage.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Different hair care practices and conditions affect African American hair and scalp health, requiring specialized knowledge for treatment.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Certain hairstyles and less hair oil use in African American girls can lead to scalp conditions like traction alopecia and seborrheic dermatitis.

The study concluded that a special imaging technique showed women with hair loss have slower hair growth and a faulty hair replacement cycle.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Pill organizers and cutters can help with taking medication regularly but may affect the medication's effectiveness and safety.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

The conclusion is that combining social and cultural factors with pharmaceutical research could improve our understanding of how drugs work.

Hair loss after bariatric surgery can be reduced by staying hydrated, eating enough protein, taking vitamins, managing stress, and possibly using biotin.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.